Iradimed (IRMD) Net Cash Flow Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Iradimed | 1.17 Bn | 1.11 Bn | 16.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48.06% |
| Dec 31, 2025 | -32.80% |
| Sep 30, 2025 | 11.03% |
| Jun 30, 2025 | 26.54% |
| Mar 31, 2025 | -29.54% |
| Dec 31, 2024 | -36.20% |
| Sep 30, 2024 | -12.51% |
| Jun 30, 2024 | 4.48% |
| Mar 31, 2024 | -36.84% |
| Dec 31, 2023 | -6.96% |
| Sep 30, 2023 | -17.19% |
| Jun 30, 2023 | 19.73% |
| Mar 31, 2023 | -58.63% |
| Dec 31, 2022 | 69.09% |
| Sep 30, 2022 | 16.42% |
| Jun 30, 2022 | 35.74% |
| Mar 31, 2022 | -114.03% |
| Dec 31, 2021 | 16.24% |
| Sep 30, 2021 | -4.00% |
| Jun 30, 2021 | 26.71% |
| Mar 31, 2021 | 16.97% |
| Dec 31, 2020 | -8.08% |
| Sep 30, 2020 | -7.57% |
| Jun 30, 2020 | -13.07% |
| Mar 31, 2020 | -2.63% |
| Dec 31, 2019 | 20.68% |
| Sep 30, 2019 | -14.81% |
| Jun 30, 2019 | 15.15% |
| Mar 31, 2019 | 29.95% |
| Dec 31, 2018 | 59.56% |
| Sep 30, 2018 | 85.22% |